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The efficacy of three oral formulations (gelatin capsule, tablet, oil base) and
five dosages (50, 100, 250, 500, 1000 yg) of cabergoline to disrupt reproduction in coyotes (Canis latrans) was evaluated. The type of formulation
used had no effect on plasma progesterone and prolactin concentrations or
o n mean litter size. N o adverse side effects (for example, vomiting, anorexia,
diarrhoea) were observed despite the use of doses of up to 20 times the
therapeutic dose used for domestic dogs and cats. All coyotes treated with 50,
100, 250 and 500 y g cabergoline whelped, but plasma progesterone concentrations in these coyotes were lower ( P s 0.07) than in control animals
at day 7 after treatment. Ten of 11 females treated with 1000 y g cabergoline
whelped, but progesterone concentrations in these coyotes were lower
than in control animals up to day 14 after treatment ( P S 0.04). Dosages
of 1000 yg cabergoline decreased blood serum prolactin ( P s 0.1 0) and
progesterone ( P c 0.06) concentrations, but apparently failed to decrease
progesterone below the threshold necessary to maintain pregnancy in all but
one animal. However, progressive inhi bition ol' prolactin and progesterone
with increasing doses of cabergoline indicated that higher dosages might be
effective in coyotes. Survival of pups born to cabergoline-treated females was
not different ( P < 0.001) from that of pups born to control teniales, but mean
litter size was smaller for females treated with cabergoline ( P s 0.073) than
for the control females. Although all cabergoline treatments in this study were
ineffective at preventing reproduction in coyotes, progressive inhibition of
prolactin and progesterone with increasing dosages of cabergoline indicates
that higher doses might be effective in preventing reproduction in coyotes.
However, the physiological differences from other canine species in
dopamine D2 receptors and mechanisms of luteal support may ultimately
prevent the use ot cabergoline tor reproductive control in coyotes.

Introduction
Coyotes (Canis latrans) are one of the most widely distributed predators in North America
(Bekotf and Wells, 1980) and depredation of domestic livestock by coyotes has been, and
Email: ThomasJ.DeLiberto@aphis.usda.gov
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continues to be, a serious threat to animal production in the western USA. A number of both
wild and domestic species, such as cattle, deer and antelope, can experience losses due to
coyotes, but depredation of sheep is most economically significant, resulting in annual losses
estimated at $1 7.7 million (US Department of Agriculture, 1995).
Losses incurred by coyotes on livestock have traditionally been managed by lethal means,
such as aerial hunting, trapping and poisoning (Kirkpatrick and Turner, 1985). The effectiveness of these techniques is variable and dependent on environmental conditions, terrain, coyote
density, and the magnitude and nature of the problems (Knowlton et a/., 1999). Recently, there
has been increased public resistance and criticism of these traditional control methods. Thus, for
the successful resolution of depredation problems, producers and resource managers need to
incorporate a variety of techniques that integrate social, ethical and economic concerns, as well
as the biology of the species, in the development of management strategies.
The use of reproductive intervention strategies as a means for reducing human-wildlife
conflicts has re-surfaced in recent years (DeLiberto etal., 1999). Application of such strategies
to predators will probably be considered a humane alternative to lethal control, particularly if
it preserves social structure and minimizes impact to non-target species.
In their breeding pair hypothesis, Till and Knowlton (1983) suggested that reproductive
control in coyotes would be effective at reducing depredation of sheep. They indicated that
many depredation problems caused by coyotes are from territorial adults providing for their
young. These adult coyotes switch from feeding principally on small and medium prey, to
killing larger species such as lambs. Till and Knowlton (1983) assumed that territorial breeders
are the principal killers of livestock, and that depredations were linked to the presence of
pups. In a field test of this hypothesis, Bromley and Cese (2001) demonstrated that coyote
packs that had undergone tubal ligation and vasectomy maintained territories and predated
on sheep less than did unaltered packs. Their work indicates that the development of
reproductive inhibition techniques for coyotes that do not interfere with territorial behaviour
would be valuable in reducing predation on sheep.
Experiments on reproductive inhibition in coyotes have been conducted, but there have been
problems associated with an effective delivery system for most compounds studied (DeLiberto
etal., 1999). If effective in coyotes, cabergoline may have potential use in controlling reproduction by circumventing this problem. Cabergoline is an ergot derivative that acts as a dopamine
agonist, resulting in a prolonged effect of reducing prolactin concentration. Cabergoline has
fewer or no side effects, is relatively species specific, and is currently available in an oral form.
Studies have demonstrated that prolactin is an essential luteotrophic hormone in domestic
dogs and cats, and in red foxes (Vulpes vulpes) and silver foxes (Vulpes vulpes fulva)
(Concannon et a/., 1987; Post etal., 1988; Okkens et a/., 1990; Valberg and Mondain-Monval,
1992; Onclin et a/., 1993; Jochle, 1997). Therefore, compounds such as cabergoline that
inhibit prolactin secretion cause regression of the corpora lutea and a subsequent decrease in
circulating progesterone, ultimately resulting in the termination of pregnancy (Concannon
et a/., 1987; Post et al., 1988; Okkens et al., 1990, 1993; Jochle and Jijchle, 1993; Lengwinat
et a/., 2001; Marks et al., 2001 ). The aim of the present study was to evaluate the use of
cabergoline as an effective reproductive inhibitor in coyotes. Five doses of cabergoline in three
formulations administered during the last two stages of pregnancy were evaluated.

Materials and Methods
Study site, animals and general procedures
Studies were performed at the United States Department of Agriculture (USDA) National
Wildlife Research Center (NWRC), Predation Ecology and Behavior Field Station (Millville,
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UT). The NWRC, Institutional Animal Care and Use Committee approved all procedures in
this study as protocol QA-691. Experiments were conducted between 1999 and 2001 using
adult coyotes (3-8 years old), 9-11 kg body weight, which were obtained from the captive
breeding colony at the Field Station. All animals used in this study had established breeding
histories at the Station. The animals were born and raised by staff to minimize stress from
routine handling and blood collection procedures.
In December of each year, male and female coyotes were placed in 0.1 ha pens and
allowed to form pair bonds before the onset of oestrus in late January.Two open-sided shelters
(0.75 m X 1.OO m) were provided in each pen for shade, and breeding pairs had access to an
insulated den box (1.0 m diameter) with corn cob bedding. Coyotes were fed a daily ration
consisting of meat slurry, and water was provided ad libitum.
Breeding and mating behaviours were documented by observers inside a building located
between 300 m and 500 m from the pens. In Expt 1, pregnancies were confirmed by
abdominal palpation 28-35 days after the first copulation. In Expts 2 and 3, pregnancies were
verified by the detection of the pregnancy-specific hormone, relaxin, in blood plasma, using a
commercially available ELlSA for canines (REPROCHECKo; Synbiotics, Inc., San Diego, CA),
validated for use in coyotes (Carlson and DeLiberto, 2001). Gestation in coyotes is about
62-66 days, similar to that in domestic dogs (Concannon et al., 1983). Coyote pairs were
maintained in breeding pens for at least 1 month after their expected whelping date (that is,
late March-April) on the basis of the first observed copulation.
Treatnierits
Expt 1 was conducted in 1999 by randomly assigning pregnant female coyotes and their
mates to 50 (n = 5) or I 0 0 p g (n = 3) cabergoline treatment groups or to a control group
( n = 6). In each treatment group, cabergoline (Galastopo; Jansen-Cilag, Neuss) was administered for 7 consecutive days starting on days 38-42 of gestation. Cabergoline was administered orally by mixing the compound in the daily food ration.
Expt 2 was initiated in 2000 by assigning 18 pregnant female coyotes and their mates to
250 and 500 yg cabergoline treatment groups and to a control group (n = 6 female coyotes
per group). Female coyotes in each treatment group were given cabergoline in tablet form
(Dostinexo; Pharmacia Corp., Peapack, NJ)for 7 consecutive days starting on days 32-38 of
gestation. Cabergoline was administered by placing tablets in the posterior portion of the oral
cavity and ensuring that the animals swallowed the dose. Control animals were handled in the
same manner as cabergoline-treated coyotes, except that all animals received an empty
gelatine capsule.
A third experiment was performed in 2001 to evaluate the effects of 1000 pg cabergoline
administered in three different formulations. Pregnant females were assigned to the following
treatments: (i) cabergoline administered in gelatin capsules (n = 3); (ii) cabergoline in tablet
form (Dostinexo; n = 5); and (iii) cabergoline in fractionated coconut oil i n = 6). All formulations were administered by placing the dose into the posterior portion of the oral cavity and
ensuring that the animals swallowed the dose. Treatments were administered for 7 consecutive days starting on days 32-38 of gestation.
Hormone and cabergoline analyses
In all experiments, blood samples were obtained by cephalic venepuncture from coyotes
immediately before treatment, and at days 3, 7 and 14 after the first dose. Samples were
centrifuged at 900-1 000 gfor 15 min and the supernatant was removed and frozen at -20°C.
In Expt 1, progesterone in the blood was determined quantitatively using Coat-A-CountB
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radioimmunoassay kits (Diagnostic Products Corporation, Los Angeles, CA) validated for use in
dogs (Srikandakumar etal., 1986; Willard etal., 1986). We validated the assay for use in coyotes
using two techniques. Recovery of progesterone in sera collected from female coyotes during
anoestrus and spiked with either 2 or 19 ng progesterone ml-' was 95 and loo%, respectively.
This serum was also spiked with the kit standards (1 : I dilution) in a test for linearity that yielded a
0.995 correlation. A test for parallelism on four coyote serum samples diluted 1 :32 yielded
recoveries from 95 to 101Oh,. The intra- and interassay coefficients of variation for analysis of
experimental samples were 5.1 and 5.6%, respectively, within the range of 1-40 ng ml-'.
In Expts 2 and 3, blood serum concentrations of progesterone were determined quantitatively using radioimmunoassay techniques described by Niswender (1973). The intra- and
interassay coefficients of variation were < 0.78 and 6.47'%, respectively. Progesterone concentrations on days 2, 7 and 14 in all experiments were calculated as a percentage change
from pretreatment concentrations for all coyotes.
Prolactin assays were not determined for the 50 and 100 pg cabergoline treatments because an
appropriate assay was unavailable during Expt 1. Blood serum concentrations of prolactin were
determined in coyotes during Expts 2 and 3 on days 2, 7 and 14 by the Colorado State University
(Animal Reproduction and Biotechnology Laboratory, Fort Collins). Radioimmunoassay for
prolactin used a highly purified canine prolactin antigen for iodination AFP2451 B, canine
prolactin reference preparation and anti-canine prolactin (guinea-pig)antiserum AFP1062091 GP
obtained from the National Hormone and Pituitary Program, National Institute of Diabetes
and Digestive and Kidney Disease at the National Institutes of Health. The intra- and interassay
respectively. Prolactin concentrations were
coefficients of variation were < 6.47 and 4.01
calculated as a percentage change from pretreatment concentrations.
Blood plasma concentrations of cabergoline were determined using electrospray ionization tandem mass spectrometry (Kimball etal., 2001). The recent development of this quantitative method allowed for measurement of cabergoline concentrations in Expt 3 only.

Statistical analysis
ANOVA was used to evaluate the effects of cabergoline treatments on litter size. Concentrations of serum progesterone and prolactin, and plasma cabergoline were evaluated with
repeated measures ANOVA. Fisher's least significance difference tests were used to compare
treatment means, when ANOVA detected differences among effects using a type I error rate of
a = 0.1 0.

Results
Litter size
All coyotes that received 50, 100, 250 or 500 pg cabergoline and all control animals
whelped. In addition, all animals administered 1000 pg cabergoline in gelatin capsules and
tablets also whelped. Only one of six coyotes that received 1000 pg cabergoline oil-based
treatment failed to whelp. This animal was observed with a bloody vaginal discharge on day 6
of treatment (approximately day 38 of gestation).
No difference was observed in litter size among the three formulations of 1000 pg cabergoline. Consequently, these data were analysed as one treatment. Mean litter size in control
animals was higher ( P s 0.07) than in all treatment groups (Table 1).

Hormone and cabergoline analyses
Progesteroneconcentrations in all but two coyotes were maintained above 4 ng ml-'. No significant difference was observed in mean percentage change of progesterone concentrations
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Table 1. Mean litter size of temale coyotes (Canis latrdns) that receivecl one ot five oral tlosages ot calxrgoline
on 7 consecutive days cluring the last t w o phases of pregnancy
Treatment

Litter sire inlean i SD)

IJ

Control
Cabergoline ipg)
50
100

250
50 0
1000
,'"Values with tlitterrnt suljcJr\cripts ~lrc~signiiicantly
dittrrent ( P c 0.05).

Treatment
a,

Control
a

50 pg

100 pg

250 pg

500 pg

1000 pg

201

Fig. 1. Mean percentage change of serum progesterone concentrations in
and day 14 ( W ) after
female c-oyotes (C'lnis latrans) at day 3 (H),day 7 (0)
oral '~dministrationof one ot five dosages of cabergoline. Aninials treated
with 5 0 anti 100 p g c-ahergoline were treated between day 38 and day 4'1 of
gestation. Coyotes treated with 2.50,500 and 1000 pg cabergoline were
treated hetween day 32 and day 40 oC gestation. $""Bars within days with
different letters are significantly different ( P < 0.1 0 ) .

from pretreatment concentrations among the three formulations of 1000 p g cabergoline.
Consequently, these data were combined and analysed as one treatment. By day 3 of the
treatment period, progesterone concentrations were lower than pretreatment concentrations
for all treatment groups (Fig. 1). However, only mean percentage changes in progesterone
concentrations in coyotes treated with 100 and 1000 yg cabergoline were significantly
different from those of the control animals ( P G 0.04). By day 7, decreases in progesterone
concentrations were higher in all treatment groups ( P s 0.06) than in the control animals, and
the greatest decrease was observed in the 1000 yg cabergoline group (Ps 0.01 1. Differences
between control and treatment groups persisted for only the 1000 yg cabergoline group at day
14 ( P s 0.02).

Treatment
40,

Control

2 5 0 Pg

5 0 0 Pg

1000 y g

Fig 2. Mean percentage change of serum prolactin concentrations in
female coyotes (Canis latrans) at day 3 (D),day 7 (0)
and day 14) . (
after oral administration of one of five dosages of cabergoline. Animals
treated with 50 and 100 y g cabergoline were treated between day 38
and day 49 of gestation. Coyotes treated with 250, 500 and 1000 y g
cabergoline were treated between day 32 and day 40 of gestation.
""Bars within days with different letters are significantly different
( P < 0.10).

No significant difference was observed in the mean percentage change of prolactin concentrations from pretreatment concentrations among the three different formulations of
1000 pg cabergoline. Consequently, these data were combined and analysed as one treatment. Mean changes in prolactin concentrations did not differ between the control group and
250 pg cabergoline group at any sample period (Fig. 2). No decreases in prolactin from
pretreatment concentrations were observed during any of the periods in either of these groups.
Decreases in prolactin were observed during all sample periods in the 500 and 1000 yg
cabergoline treatment groups (Fig. 2). Mean percentage changes in prolactin concentrations
for the 500 pg cabergoline treatment group were different from the control group (P -S 0.04)
and the 250 pg cabergoline treatment group (P G 0.1 0) at day 3 and day 14.
The greatest decreases in prolactin were observed in animals treated with 1000 pg
cabergoline. Mean percentage changes in prolactin in this group were different from the
control group (P G 0.01 ) and the 250 p g cabergoline treatment group (P < 0.03) at all sample
periods. Differences were also observed between the 500 and 1000 pg cabergoline groups at
day 3 (P = 0.1 0) and day 7 (P = 0.04), but these differences did not persist up to day 14.
Mean plasma concentrations of cabergoline were not different among animals treated with
the three formulations of 1000 pg cabergoline. Consequently, data were combined and a
single mean value was calculated for each time period. Plasma concentrations of cabergoline
increased throughout the first 14 days after treatment (Fig. 3). From day 14 to day 42 after
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3

14
23
30
Days after treatment

7

38

42

Fig 3. Mean plasma cabergoline concentrations in female coyotes
(Canis latrans) after oral administration of 1000 pg cabergoline for
7 consecutive days between day 32 and day 40 of gestation.

treatment (that is, about 36 days of gestation up to 12 days after whelping), cabergoline
concentrations stabilized between 14 480 and 18 125 pg ml-I.
Expt 3 produced the only instance in which progesterone concentrations of a pregnant
coyote were consistently below 4 ng ml-' and failed to whelp. Treatment with 1000 yg
cabergoline caused marked decreases in mean prolactin and progesterone concentrations.
Mean percentage changes in prolactin concentrations of -42.1, -38.2 and -1 1.8 at days 3, 7
and 14, respectively, resulted in corresponding decreases in progesterone concentrations of
-55.6, -65.7 and -62.3%, respectively. All of these decreases were different from those in
control animals, but were only sufficient in the individual that failed to whelp. It is likely that a
threshold of progesterone similar to that of other canine species (that is, 2 ng mi-') is required
for the maintenance of pregnancy in coyotes (Concannon and Hansel, 1977; Johnston et a/.,
2001 ). Only two animals had progesterone concentrations approaching this threshold. In one
animal there was a decrease in progesterone concentrations from 46.5 ng ml-I before
treatment to 2.7, 6.9 and 10.7 ng ml-I at days 3, 7 and 14 after treatment, respectively (Fig.
4b). This individual whelped four puppies at about day 62 after the first observed copulation.
The progesterone concentrations of the second animal decreased from 32.1 ng ml-' before
treatment to 3.8, 2.5 and 3.22 ng ml-' at days 3, 7 and 14 after treatment, respectively (Fig.
4a). This decrease and maintenance of progesterone concentrations below 4 ng ml-' probably
resulted in termination of pregnancy. Furthermore, if coyotes are similar to other canines, it is
likely that progesterone concentrations in this animal decreased below 2 ng ml-'. The inability
to detect a decrease in progesterone below 2 ng ml-I in the present study was probably a
consequence of the sampling design; daily blood sampling may have been necessary to detect
a decrease below threshold.

Discussion
Although all animals treated with cabergoline in Expt 1 whelped, endocrine data indicate that
higher doses might have been effective. Mean progesteroneconcentrations for animals treated
with 50 pg cabergoline were lower than in control animals at day 7, and for animals treated

0

3
7
Days after treatment

14

0

3
7
Days after treatment

14

" ,

Fig 4. (a) Concentrations of prolactin (0)
and progesterone
(@) in a pregnant female coyote ( C J I J ~bSt r a ~ sthat
)
failed to
whelp atter t w o treatments of 1000 pg cabergoline. (h)Concentr,~tions of prolac-tin (0)
and progesterone (@) in '1 pregnant female coyote that whelped after t w o treatnients of
1000 p g cabergoline.

with 100 y g cabergoline at day 3 and day 7 . Progesterone concentrations in these animals
were also consistently lower than pre-dose concentrations. These data indicate that inhibition
of pituitary prolactin secretion was insufficient to maintain an adequate suppression of luteal
progesterone secretion below 4 ng mlF1.Thus, the dose of cabergol ine was increased in Expt
2, in an attempt to reduce progesterone concentrations below this threshold. However,
administration of 250 and 500 yg cabergoline too was ineffective at terminating pregnancy in
all coyotes. Progesterone concentrations in this experiment failed to decrease below the
threshold that is thought to be necessary for the maintenance of pregnancy. Mean progesterone concentrations in coyotes treated with 250 and 500 yg cabergoline were not different
from progesterone concentrations observed in the 50 and 100 yg treatment groups in Expt 1 .
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Although the pattern of progesterone suppression appeared to be similar in animals treated
with 50, 100 and 250 yg cabergoline (that is, a gradual trend toward pretreatment concentrations from day 3 to day 14), the pattern was apparently reversed in animals treated with
500 pg cabergoline. In this treatment group, mean progesterone concentrations tended to
decrease up to day 14, indicating a prolonged effect of cabergoline. Thus, it appeared that
therapeutic doses of cabergoline had not been administered in Expts 1 and 2, and Expt 3 was
initiated to evaluate 1000 yg cabergoline, a dose about 20 times the therapeutic dose used tor
domestic dogs and cats (Post etal., 1988; Onclin and Verstegen, 1996).
Failure of all doses of cabergoline to terminate pregnancy in all but one animal leaves little
doubt of the ineffectiveness of this compound in coyotes at dosages of up to 20 times the
therapeutic dose used in domestic dogs and cats, and in red and silver foxes (Post etal., 1988;
Onclin and Verstegen, 1996; Lengwinat et dl., 2001 ; Marks et al., 2001 ). The present study
demonstrates that there are basic physiological differences among coyotes and other
carnivores. Four potential differences are: (i) that the digestive physiology of coyotes interfered
with gastrointestinal absorption of cabergoline; (ii) that the dopamine D2 receptors in the
anterior pituitary of coyotes had lower affinity tor cabergoline than in other carnivores; (iii)
that alternative sources of prolactin or progesterone are present in coyotes; and (iv) that unlike
in other carnivores, prolactin was not a luteotrophic agent in coyotes.
It is unlikely that the digestive physiology of the coyote interfered with the absorption of
metabolically active cabergoline. Blood plasma analysis in Expt 3 revealed the presence of
cabergoline by day 3 of treatment, showed an increase at day 7 and reached a plateau by day
14, which was maintained throughout whelping. These cabergoline concentrations are
consistent with those reported in humans that received 36-85 pg kg-' (Persiani etal., 1992).
Therapeutic decreases in prolactin of 12.0-96.8% after administration of 5-50 p g cabergoline kg-' have been reported in other species (Negishi and Koide, 1997; Onclin and
Verstegen, 1997; Lengwinat et dl., 2001). Decreases in coyote prolactin concentrations of
6-42% were achieved only after treatment with 50 and 100 yg cabergoline kg-', indicating
that dopamine D2 receptors in coyotes have a lower affinity for cabergoline than they do in
other species. A genetic link between affinity for cabergoline and dopamine D2 receptors may
doses of cabergoline in wolf-dog hybrids (15 yg kg-') and
also occur in wolves. Therape~~tic
wolves (25 yg kg-') were three and five times higher than those in domestic dogs, respectively
(1. P. Verstegen, personal communication). If interspecific differences in D2 receptor biology
occur, higher doses of cabergoline may produce decreases in plasma prolactin concentrations
that are sufficient to decrease progesterone below the threshold for maintaining pregnancy.
Alternatively, other ergot derivatives (for example, bromocriptine) may have greater affinities
for dopamine D2 receptors and, if so, may be more suitable for terminating pregnancy in the
coyote.
It is important to note that cases of mis-mothering or unsuccessful nursing of litters by
coyotes were not observed in any of the treatment groups. In fact, pup survival was not
different between cabergoline-treated and control animals, despite the relatively large
decreases in prolactin concentrations in animals treated with 1000 pg cabergoline, and a
maintenance of relatively high concentrations of plasma cabergoline throughout whelping. In
pseudopregnant and lactating domestic bitches, treatment with 5 yg cabergoline kg-' rapidly
causes cessation of lactation (Jochle et a/., 1989). In cats treated with 5 pg cabergoline kg-'
after day 42 of pregnancy, preparations for lactation were inhibited and kittens born prematurely or at term could not be nursed but died quickly (Jochleand Jochle, 1983).
Furthermore, no adverse side effects (for example, vomiting and anorexia) were observed
in any of the coyotes during the experiments despite the fact that doses of up to 20 times those
used in dogs and cats were administered. Previous research on domestic dogs and cats
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demonstrated such side effects with much lower doses of cabergoline (Post etal., 1988; Jochle
et a/., 1989; Onclin and Verstegen, 1996). This observation, combined with the apparent
difference in the effect of cabergoline on lactation between coyotes and domestic animals,
provides further evidence for the insensitivity of coyotes to the compound.
Administration of higher doses of cabergoline may fail to decrease sufficiently prolactin or
progesterone if alternative sources of these hormones are present in coyotes. Such sources
may include the fetoplacental unit. It was possible that by day 14 after administration of the
first dose (that is, about day 46 of gestation), maintenance of pregnancy was under complete
or partial control of the placenta. A transfer of placental support has been documented in
domestic cats. Cabergoline was efficacious in domestic cats only when administered between
day 28 and day 42 of gestation (Jochle et a/., 1989; Verstegen et al., 1993). Before day 28,
placental support was thought to be multi-factorial. After day 42, progesterone produced by
the placenta was sufficient to maintain pregnancy. However, in domestic dogs, the placenta
does not appear to be capable of synthesizing large amounts of progesterone (Kiso and
Yamauchi, 1984). Unfortunately, only limited information on the reproductive physiology of
coyotes is available, and the mechanisms of placental support have not been identified.
Although the last three hypotheses may have influenced the effectiveness of cabergoline, it
is also possible that hormones other than prolactin contributed to the maintenance of corpora
lutea. Concannon (1 980) and Concannon et al. (1987) proposed that LH was luteotrophic
during the first phase of pregnancy in domestic dogs; prolactin became luteotrophic about
mid-way through the second stage of pregnancy. Significant reductions in circulating progesterone concentrations observed in the present study indicate that cabergoline treatments
negatively affected corpora lutea; smaller litter sizes in cabergoline-treated than in control
coyotes supported this conclusion. Thus, prolactin may have provided only partial support for
corpora lutea.
In domestic dogs, it is generally accepted that prolactin is the main, if not the only,
luteotrophic factor. Concannon et al. (1987) demonstrated depression of luteal progesterone
secretion by administration of anti-LH serum and by bromocriptine, thereby providing
evidence for at least two luteotrophins in domestic dogs. However, when LH was suppressed
by administration of a gonadotrophin-releasing hormone agonist, progesterone secretion was
not affected, indicating that LH is not the primary luteotrophic factor (Okkens et a/., 1990).
Unfortunately, the role of low LH concentrations on luteal function has not been elucidated.
The specific role of LH and prolactin in maintaining progesterone concentrations throughout pregnancy in coyotes remains unclear. LH may play a more important role in maintaining
luteal function and, consequently, the maintenance of pregnancy in coyotes than in domestic
dogs. We are currently comparing LH concentrations in non-pregnant and pregnant animals.
In addition, evaluation of LH concentrations in coyotes treated with cabergoline is also being
conducted.
Although disruption of reproduction was successful in only one coyote, the present study
indicates that higher dosages of cabergoline might be effective. For example, litter sizes were
36-44% lower in cabergoline-treated females than in control animals. It is possible that this
decrease was due to cabergoline and not to an artefact of the methodology. All coyotes were
raised at the Field Station and received extensive handling before the initiation of the study. In
addition, control coyotes were handled in the same manner as treatment animals, except that
they were given placebos. Finally, the reduction in litter sizes in carbergoline-treated animals
was observed during the three breeding seasons in which the experiments were conducted.
Progressive inhibition of prolactin and progesterone with increasing doses of cabergoline
indicate that higher doses of cabergol ine would have been effective in controlling reproduction.
Future research should evaluate higher doses of cabergoline in pregnant coyotes. In addition,
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elucidation of the mechanisms ot luteal and placental support in coyotes will be invaluable in
advancing our understanding of coyote reproductive physiology, and in designing and
evaluating strategies for disrupting it.
The Sheep a n d G o a t Predator Management Board, San Angelo, TX a n d t h e U S D A supported this research.
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D. Carlson, D. Jones, and t h e staff o f the National W i l d l i f e Research Center, Predation Ecology a n d Behavior
Project for assistance i n data collection. T. Wierenga, USDA-ARS Poisonous Plant Laboratory, a n d X. Sha,
C o l o r a d o State University A n i m a l Reproduction a n d Biotechnology Laboratory, pertornled h o r m o n e assays.
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